Shu‐Wing Ng

2.9k total citations · 1 hit paper
41 papers, 2.2k citations indexed

About

Shu‐Wing Ng is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Shu‐Wing Ng has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Reproductive Medicine. Recurrent topics in Shu‐Wing Ng's work include MicroRNA in disease regulation (8 papers), Ovarian cancer diagnosis and treatment (8 papers) and Pregnancy and preeclampsia studies (6 papers). Shu‐Wing Ng is often cited by papers focused on MicroRNA in disease regulation (8 papers), Ovarian cancer diagnosis and treatment (8 papers) and Pregnancy and preeclampsia studies (6 papers). Shu‐Wing Ng collaborates with scholars based in United States, Australia and Hong Kong. Shu‐Wing Ng's co-authors include Daniel K. Nomura, Sherry Niessen, Benjamin F. Cravatt, Jonathan Z. Long, Heather Hoover, Errol R. Norwitz, Ross S. Berkowitz, Gabriella A. Norwitz, Mihaela Pavličev and Carlos Simón and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Shu‐Wing Ng

40 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis

2009 768 citations Shu‐Wing Ng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu‐Wing Ng United States	22	1.1k	698	415	378	330	41	2.2k
Tsunekazu Kita Japan	24	876 0.8×	222 0.3×	505 1.2×	137 0.4×	367 1.1×	89	1.8k
Andelko Hrzenjak Austria	32	1.4k 1.2×	604 0.9×	81 0.2×	224 0.6×	160 0.5×	63	2.5k
Tsuyoshi Ohta Japan	24	822 0.7×	341 0.5×	273 0.7×	166 0.4×	144 0.4×	68	1.7k
Hanna Romanowicz Poland	19	945 0.8×	594 0.9×	346 0.8×	271 0.7×	237 0.7×	84	1.8k
Masami Kusaka Japan	25	1.1k 1.0×	488 0.7×	289 0.7×	80 0.2×	52 0.2×	47	2.2k
Oliver Treeck Germany	25	734 0.7×	340 0.5×	289 0.7×	181 0.5×	145 0.4×	87	1.7k
Haifeng Zhang China	25	1.9k 1.7×	1.0k 1.5×	59 0.1×	433 1.1×	56 0.2×	48	2.9k
Youji Feng China	29	1.2k 1.0×	506 0.7×	388 0.9×	217 0.6×	250 0.8×	56	1.9k
Suzanne E. Wardell United States	28	1.6k 1.5×	1.0k 1.5×	85 0.2×	316 0.8×	63 0.2×	50	3.4k
Junji Mitsushita Japan	15	751 0.7×	219 0.3×	78 0.2×	528 1.4×	126 0.4×	23	1.4k

Countries citing papers authored by Shu‐Wing Ng

Since Specialization

Citations

This map shows the geographic impact of Shu‐Wing Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Wing Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Wing Ng more than expected).

Fields of papers citing papers by Shu‐Wing Ng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Wing Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Wing Ng. The network helps show where Shu‐Wing Ng may publish in the future.

Co-authorship network of co-authors of Shu‐Wing Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Wing Ng. A scholar is included among the top collaborators of Shu‐Wing Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Wing Ng. Shu‐Wing Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ng, Shu‐Wing, Shu‐Kay Ng, Felice Arcuri, et al.. (2025). Preeclampsia is Associated with Altered Expression of Ferroptosis Biomarkers in Placental but not Maternal Vasculature. Reproductive Sciences. 32(9). 3074–3085.

Ng, Shu‐Wing, et al.. (2023). Ferroportin expression and regulation in human placenta/fetal membranes: Implications for ferroptosis and adverse pregnancy outcomes. Reproductive Biology. 23(4). 100816–100816. 9 indexed citations

Yang, Junzheng, Shubai Liu, Ka Kui Tong, et al.. (2020). MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread. Oncogene. 39(20). 4045–4060. 15 indexed citations

Ng, Shu‐Wing, et al.. (2020). Endometriosis: The Role of Iron Overload and Ferroptosis. Reproductive Sciences. 27(7). 1383–1390. 91 indexed citations

Bahrampour, Abbas, Shu‐Kay Ng, Wei Qiu, et al.. (2020). Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer. Scientific Reports. 10(1). 20071–20071. 21 indexed citations

Yamamoto, Cindy M., Melanie Oakes, Taku Murakami, et al.. (2018). Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers. Journal of Ovarian Research. 11(1). 20–20. 55 indexed citations

Yang, Junzheng, Shu‐Kay Ng, Kuan‐Chun Huang, et al.. (2017). Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. BMC Cancer. 17(1). 422–422. 11 indexed citations

Huang, Kuan‐Chun, Junzheng Yang, Shu‐Kay Ng, et al.. (2016). Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells. European Journal of Cancer. 67. 152–163. 34 indexed citations

Zhang, Yanli, Jamie Sui-Lam Kwok, Minghua Liu, et al.. (2016). Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells. Oncotarget. 7(10). 11397–11411. 30 indexed citations

10.

Lui, Kathy O., Duncan Howie, Shu‐Wing Ng, et al.. (2014). Tolerance induction to human stem cell transplants with extension to their differentiated progeny. Nature Communications. 5(1). 5629–5629. 25 indexed citations

11.

Tang, Liangdan, et al.. (2013). Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer. Gynecologic Oncology. 131(1). 69–76. 10 indexed citations

12.

Shoni, Melina, et al.. (2013). p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases. Gynecologic Oncology. 131(3). 759–763. 2 indexed citations

13.

Yang, Junzheng, Shu‐Kay Ng, Shubai Liu, et al.. (2012). Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures. BMC Cancer. 12(1). 329–329. 54 indexed citations

14.

Medarova, Zdravka, Mohanraja Kumar, Shu‐Wing Ng, & Anna Moore. (2009). Development and Application of a Dual-Purpose Nanoparticle Platform for Delivery and Imaging of siRNA in Tumors. Methods in molecular biology. 555. 1–13. 15 indexed citations

15.

Tang, Liangdan, Junzheng Yang, Shu‐Kay Ng, et al.. (2009). Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer. European Journal of Cancer. 46(1). 170–179. 32 indexed citations

16.

Ng, Shu‐Wing, et al.. (2008). Expression and significance of RhoA protein in epithelial ovarian cancer cells. 2(3). 147–150. 1 indexed citations

17.

Ehrlich, Joshua R., Liangdan Tang, Robert Caïazzo, et al.. (2008). The “Reverse Capture” Autoantibody Microarray:. Methods in molecular biology. 441. 175–192. 11 indexed citations

18.

Saxena, D.M., Gary K. Yiu, Xiaoyan Ni, et al.. (2004). Characterization of promoter elements involved in the down-regulation of topoisomerase IIα expression in a drug-resistant cell line. Gene. 342(1). 145–155. 5 indexed citations

19.

Fülöp, Vilmos, David R. Genest, Ross S. Berkowitz, et al.. (1998). DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene. 17(4). 419–424. 69 indexed citations

20.

Ng, Shu‐Wing, Yan Liu, & Lowell E. Schnipper. (1997). Cloning and characterization of the 5′-flanking sequence for the human DNA topoisomerase II beta gene. Gene. 203(2). 113–119. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact